Payoneer Announces Second Quarter 2022 Financial Results
Payoneer reported strong financial results for Q2 2022, achieving a 34% year-over-year revenue growth to $148.2 million. Transaction costs decreased to 17.7% of revenue, improving net income to $4.4 million.
Adjusted EBITDA saw a remarkable 2,087% increase to $14.7 million. The company raised its 2022 revenue guidance to $580 million - $590 million and adjusted EBITDA guidance to $30 million - $35 million.
- 34% revenue growth to $148.2 million year-over-year.
- Adjusted EBITDA increased by 2,087% to $14.7 million.
- Raised 2022 revenue guidance to $580 million - $590 million.
- Transaction costs decreased to 17.7% of revenue.
- 50% revenue growth in emerging markets.
- B2B AP/AR volumes grew over 65% year-over-year.
- None.
Q2 2022 Revenue Growth of
Second Quarter 2022 Financial Highlights |
||||||||||||||||||
($ in mm) |
|
2Q 2021 |
|
|
3Q 2021 |
|
|
4Q 2021 |
|
|
1Q 2022 |
|
|
2Q 2022 |
|
YoY
|
||
Revenue | $ |
110.9 |
|
$ |
122.7 |
|
$ |
139.2 |
|
$ |
137.0 |
|
$ |
148.2 |
|
34 |
% |
|
Transaction costs as a % of revenue |
|
25.7 |
% |
|
20.1 |
% |
|
20.2 |
% |
|
18.7 |
% |
|
17.7 |
% |
(800 bps) | ||
Revenue less transaction costs | $ |
82.4 |
|
$ |
98.0 |
|
$ |
111.1 |
|
$ |
111.4 |
|
$ |
122.0 |
|
48 |
% |
|
Net income (loss) |
|
(12.4 |
) |
|
0.8 |
|
|
(18.9 |
) |
|
20.2 |
|
|
4.4 |
|
N.M. | ||
Adjusted EBITDA |
|
0.7 |
|
|
6.1 |
|
|
13.5 |
|
|
10.4 |
|
|
14.7 |
|
2,087 |
% |
|
Operational Metrics | ||||||||||||||||||
Volume ($bn) | $ |
13.6 |
|
$ |
13.6 |
|
$ |
16.2 |
|
$ |
14.6 |
|
$ |
14.6 |
|
8 |
% |
|
Revenue as a % of volume ("Take Rate") | 82 bps | 90 bps | 86 bps | 94 bps | 101 bps | 19 bps |
“Payoneer delivered strong revenue growth and profitability,” said
“We plan to continue to deliver positive adjusted EBITDA going forward,” said
Second Quarter 2022 Business Highlights
The Company had several achievements in the quarter, reinforcing its conviction for its long-term investment strategy and ability to drive growth across its diversified business model.
-
50% year-over-year revenue growth in its portfolio of emerging markets, which includesLatin America ,Southeast Asia ,South Asia ,Middle East ,North Africa and more -
B2B AP/AR volumes grew over
65% year-over-year and represented12% of total volume in the second quarter -
The
Payoneer ecosystem continues to expand with a significant increase in integration activity with banks and SMB platforms, including new partnerships with EC21, Linnworks, PrivatBank, and Shoplazza -
Customer funds exceeded
for the first time as of$5 billion June 30, 2022
Updated 2022 Guidance
“We are pleased with our second quarter and first half results, which highlighted the global breadth of our business and diversity of our revenue drivers,” said
“Therefore, we are raising our revenue guidance for the full year. This reflects our latest views on the evolving broader macro-economic and geopolitical environment, the diversity of geographies and industries that we serve, and the strength of our operations. It also includes our improving outlook on our business in
“We anticipate positive adjusted EBITDA for 2022 while we invest in our long-term growth. We remain confident that our continued execution, customer adoption of our higher value services, and successful penetration into high-growth regions all support our increased guidance for the full year 2022, even with uncertainty ahead around inflation, economic growth, and interest rate levels.”
Updated 2022 guidance is as follows:
|
|
|
|
|
|||
|
|
Revenue |
|
|
|
||
|
|
Transaction costs |
~ |
|
|
||
|
|
Adjusted EBITDA (1) |
|
|
|
(1) |
Please refer to “Financial Information; Non-GAAP Financial Measures” below |
Webcast
About
Since 2005,
Forward-Looking Statements
This press release includes, and oral statements made from time to time by representatives of
Financial Information; Non-GAAP Financial Measures
Some of the financial information and data contained in this press release, such as adjusted EBITDA, have not been prepared in accordance with
Non-GAAP measures include the following item:
Adjusted EBITDA: We provide adjusted EBITDA, a non-GAAP financial measure that represents our net income (loss) adjusted to exclude: M&A related income, stock-based compensation expenses, reorganization related expenses, share in losses (gain) of associated company, gain from change in fair value of warrants, other financial expense (income), net, taxes on income, and depreciation and amortization.
Other companies may calculate the above measure differently, and therefore Payoneer’s measures may not be directly comparable to similarly titled measures of other companies.
In addition, guidance for fiscal year, where adjusted, is provided on a non-GAAP basis, which
In this earnings release, we reference volume, which is an operational metric. Volume refers to the total dollar value of transactions successfully completed or enabled by our platform, not including orchestration transactions. For a customer that both receives and later sends payments, we count the volume only once, with certain limited exceptions where both received and sent payment are counted.
TABLE - 1 | ||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME (LOSS) (UNAUDITED) | ||||||||||||||||
( |
||||||||||||||||
Three months ended |
Six months ended |
|||||||||||||||
|
|
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Revenues | $ | 148,190 |
|
$ | 110,927 |
|
$ | 285,148 |
|
$ | 211,533 |
|
||||
Transaction costs ( party transaction during the three and six months ended respectively) |
26,212 |
|
28,521 |
|
51,787 |
|
48,676 |
|
||||||||
Other operating expenses | 35,392 |
|
32,010 |
|
70,151 |
|
58,624 |
|
||||||||
Research and development expenses | 26,607 |
|
18,541 |
|
52,522 |
|
35,194 |
|
||||||||
Sales and marketing expenses | 36,820 |
|
27,702 |
|
71,289 |
|
50,841 |
|
||||||||
General and administrative expenses | 20,192 |
|
18,163 |
|
38,320 |
|
28,680 |
|
||||||||
Depreciation and amortization | 5,171 |
|
4,351 |
|
9,626 |
|
9,028 |
|
||||||||
Total operating expenses | 150,394 |
|
129,288 |
|
293,695 |
|
231,043 |
|
||||||||
Operating loss | (2,204 |
) |
(18,361 |
) |
(8,547 |
) |
(19,510 |
) |
||||||||
Financial income (expense): | ||||||||||||||||
Gain from change in fair value of Warrants | 12,831 |
|
12,076 |
|
44,027 |
|
12,076 |
|
||||||||
Other financial expense, net | (4,824 |
) |
(2,937 |
) |
(7,519 |
) |
(3,559 |
) |
||||||||
Financial income (expense), net | 8,007 |
|
9,139 |
|
36,508 |
|
8,517 |
|
||||||||
Income (loss) before taxes on income and share of gain (loss) of associated company |
5,803 |
|
(9,222 |
) |
27,961 |
|
(10,993 |
) |
||||||||
Taxes on income | 1,374 |
|
3,197 |
|
3,341 |
|
4,928 |
|
||||||||
Share in gain (loss) of associated company | (7 |
) |
5 |
|
13 |
|
(1 |
) |
||||||||
Net income (loss) | $ | 4,422 |
|
$ | (12,414 |
) |
$ | 24,633 |
|
$ | (15,922 |
) |
||||
Per share data | ||||||||||||||||
Net income (loss) per share attributable to common stockholders — Basic
|
$ | 0.01 |
|
$ | (0.63 |
) |
$ | 0.07 |
|
$ | (0.84 |
) |
||||
— Diluted earnings (loss) per share | $ | 0.01 |
|
$ | (0.63 |
) |
$ | 0.07 |
|
$ | (0.84 |
) |
||||
Weighted average common shares outstanding — Basic | 345,522,076 |
|
66,744,348 |
|
345,831,177 |
|
58,702,320 |
|
||||||||
Weighted average common shares outstanding — Diluted | 366,013,696 |
|
66,744,348 |
|
369,047,627 |
|
58,702,320 |
TABLE - 2 |
||||||||||||||||
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA (UNAUDITED) | ||||||||||||||||
( |
||||||||||||||||
Three months ended |
Six months ended |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
(in thousands) |
||||||||||||||||
Net income (loss) | $ | 4,422 |
|
$ | (12,414 |
) |
$ | 24,633 |
|
$ | (15,922 |
) |
||||
Depreciation & amortization | 5,171 |
|
4,351 |
|
9,626 |
|
9,028 |
|
||||||||
Taxes on income | 1,374 |
|
3,197 |
|
3,341 |
|
4,928 |
|
||||||||
Other financial expenses (income), net | 4,824 |
|
2,937 |
|
7,519 |
|
3,559 |
|
||||||||
EBITDA | 15,791 |
|
(1,929 |
) |
45,119 |
|
1,593 |
|
||||||||
Stock based compensation expenses(1) | 11,890 |
|
10,671 |
|
24,798 |
|
14,968 |
|
||||||||
Reorganization related expenses(2) | — |
|
5,087 |
|
— |
|
5,087 |
|
||||||||
Share in losses (gain) of associated company | 7 |
|
(5 |
) |
(13 |
) |
1 |
|
||||||||
M&A related income(3) | (116 |
) |
(1,074 |
) |
(735 |
) |
(1,074 |
) |
||||||||
Gain from change in fair value of Warrants(4) | (12,831 |
) |
(12,076 |
) |
(44,027 |
) |
(12,076 |
) |
||||||||
Adjusted EBITDA | $ | 14,741 |
|
$ | 674 |
|
$ | 25,142 |
|
$ | 8,499 |
|
(1) Represents non-cash charges associated with stock-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy. | ||||||||||||
(2) Represents the non-recurring reorganizational costs that were not recorded as a reduction of additional paid in capital. The amounts relate to legal and professional services associated with the Reorganization. | ||||||||||||
(3) Represents non-recurring fair value adjustment of a liability related to our 2020 acquisition of optile. | ||||||||||||
(4) Changes in the estimated fair value of the warrants are recognized as gain or loss on the statements of operations. The impact is removed from EBITDA as it represents market conditions that are not in control of the Company. |
Three months ended, |
||||||||||||||||||||
|
|
|
|
|
||||||||||||||||
(in thousands) |
||||||||||||||||||||
Net income (loss) | $ | (12,414 |
) |
$ | 837 |
|
$ | (18,902 |
) |
$ | 20,211 |
|
$ | 4,422 |
|
|||||
Depreciation & amortization | 4,351 |
|
4,435 |
|
4,534 |
|
4,455 |
|
5,171 |
|
||||||||||
Taxes on income | 3,197 |
|
662 |
|
3,121 |
|
1,967 |
|
1,374 |
|
||||||||||
Other financial expenses (income), net | 2,937 |
|
3,306 |
|
(11 |
) |
2,695 |
|
4,824 |
|
||||||||||
EBITDA | (1,929 |
) |
9,240 |
|
(11,258 |
) |
29,328 |
|
15,791 |
|
||||||||||
Stock based compensation expenses(1) | 10,671 |
|
8,590 |
|
13,455 |
|
12,908 |
|
11,890 |
|
||||||||||
Reorganization related expenses(2) | 5,087 |
|
— |
|
— |
|
— |
|
— |
|
||||||||||
Share in losses (gain) of associated company | (5 |
) |
10 |
|
26 |
|
(20 |
) |
7 |
|
||||||||||
M&A related income(3) | (1,074 |
) |
(390 |
) |
(257 |
) |
(619 |
) |
(116 |
) |
||||||||||
Gain from change in fair value of Warrants(4) | (12,076 |
) |
(11,321 |
) |
11,573 |
|
(31,196 |
) |
(12,831 |
) |
||||||||||
Adjusted EBITDA | $ | 674 |
|
$ | 6,129 |
|
$ | 13,539 |
|
$ | 10,401 |
|
$ | 14,741 |
|
(1) Represents non-cash charges associated with stock-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy. | |||||||||||||||
(2) Represents the non-recurring reorganizational costs that were not recorded as a reduction of additional paid in capital. The amounts relate to legal and professional services associated with the Reorganization. | |||||||||||||||
(3) Represents non-recurring fair value adjustment of a liability related to our 2020 acquisition of optile. | |||||||||||||||
(4) Changes in the estimated fair value of the warrants are recognized as gain or loss on the statements of operations. The impact is removed from EBITDA as it represents market conditions that are not in control of the Company. |
TABLE - 3 | ||||||||||||||
EARNINGS (LOSS) PER SHARE (UNAUDITED) | ||||||||||||||
( |
||||||||||||||
Three Months Ended |
Six months ended |
|||||||||||||
|
|
|||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||
Numerator: | ||||||||||||||
Net income (loss) | $ | 4,422 |
$ | (12,414 |
) |
$ | 24,633 |
$ | (15,922 |
) |
||||
Less dividends and revaluation attributable to redeemable and redeemable convertible preferred stock | — |
29,611 |
|
— |
33,632 |
|
||||||||
Net income (loss) attributable to common stockholders | $ | 4,422 |
$ | (42,025 |
) |
$ | 24,633 |
$ | (49,554 |
) |
||||
Denominator: | ||||||||||||||
Weighted average common shares outstanding — | ||||||||||||||
Basic | 345,522,076 |
66,744,348 |
|
345,831,177 |
58,702,320 |
|
||||||||
Add: | ||||||||||||||
Dilutive impact of options to purchase common stock | 19,844,013 |
— |
|
22,541,797 |
— |
|
||||||||
Dilutive impact of private warrants | 647,607 |
— |
|
674,653 |
— |
|
||||||||
Weighted average common shares – diluted | 366,013,696 |
66,744,348 |
|
369,047,627 |
58,702,320 |
|
||||||||
Net income (loss) per share attributable To common stockholders — Basic earnings (loss) per share | $ | 0.01 |
$ | (0.63 |
) |
$ | 0.07 |
$ | (0.84 |
) |
||||
Diluted earnings (loss) per share | $ | 0.01 |
$ | (0.63 |
) |
$ | 0.07 |
$ | (0.84 |
) |
TABLE - 4 | |||||||||
CONSOLIDATED BALANCE SHEETS (UNAUDITED) | |||||||||
( |
|||||||||
|
|
||||||||
2022 |
2021 |
||||||||
Assets: | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 492,002 |
|
$ | 465,926 |
|
|||
Restricted cash | 3,102 |
|
3,000 |
|
|||||
Customer funds | 5,140,642 |
|
4,401,254 |
|
|||||
Accounts receivable, net | 14,334 |
|
13,844 |
|
|||||
CA receivables, net | 38,602 |
|
53,675 |
|
|||||
Other current assets | 31,206 |
|
25,024 |
|
|||||
Total current assets | 5,719,888 |
|
4,962,723 |
|
|||||
Non-current assets: | |||||||||
Property, equipment and software, net | 13,414 |
|
12,140 |
|
|||||
19,480 |
|
21,127 |
|
||||||
Intangible assets, net | 39,806 |
|
37,529 |
|
|||||
Restricted cash | 5,349 |
|
5,113 |
|
|||||
Deferred taxes | 3,834 |
|
4,900 |
|
|||||
Investment in associated company | 6,635 |
|
7,013 |
|
|||||
Severance pay fund | 1,242 |
|
1,723 |
|
|||||
Operating lease right of use assets | 19,075 |
|
12,943 |
|
|||||
Other assets | 13,564 |
|
13,541 |
|
|||||
Total assets | $ | 5,842,287 |
|
$ | 5,078,752 |
|
|||
Liabilities and shareholders’ equity: | |||||||||
Current liabilities: | |||||||||
Trade payables | $ | 26,738 |
|
$ | 17,200 |
|
|||
Outstanding operating balances | 5,140,642 |
|
4,401,254 |
|
|||||
Other payables | 73,479 |
|
79,374 |
|
|||||
Total current liabilities | 5,240,859 |
|
4,497,828 |
|
|||||
Non-current liabilities: | |||||||||
Long-term debt from related party | 14,769 |
|
13,665 |
|
|||||
Warrant liability | 15,850 |
|
59,877 |
|
|||||
Other long-term liabilities | 27,879 |
|
20,309 |
|
|||||
Total liabilities | 5,299,357 |
|
4,591,679 |
|
|||||
Shareholders’ equity: | |||||||||
Preferred stock, |
— |
|
— |
|
|||||
Common stock, issued and outstanding at |
3,464 |
|
3,404 |
|
|||||
Additional paid-in capital | 611,997 |
|
575,470 |
|
|||||
Accumulated other comprehensive income (loss) | (605 |
) |
2,253 |
|
|||||
Accumulated deficit | (71,926 |
) |
(94,054 |
) |
|||||
Total shareholders’ equity | 542,930 |
|
487,073 |
|
|||||
Total liabilities and shareholders’ equity | $ | 5,842,287 |
|
$ | 5,078,752 |
|
TABLE - 5 | ||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) | ||||||||
( |
||||||||
Six months ended |
||||||||
|
||||||||
2022 |
2021 |
|||||||
Cash Flows from Operating Activities | ||||||||
Net income (loss) | $ | 24,633 |
|
$ | (15,922 |
) |
||
Adjustment to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 9,626 |
|
9,028 |
|
||||
Deferred taxes | 1,066 |
|
344 |
|
||||
Stock-based compensation expenses | 25,275 |
|
15,128 |
|
||||
Share in loss (gain) of associated company | (13 |
) |
1 |
|
||||
Gain from change in fair value of Warrants | (44,027 |
) |
(12,076 |
) |
||||
Transaction costs allocated to Warrants | — |
|
5,087 |
|
||||
Foreign currency re-measurement loss | 2,491 |
|
861 |
|
||||
Changes in operating assets and liabilities: | ||||||||
Other current assets | (6,650 |
) |
(8,311 |
) |
||||
Trade payables | 9,538 |
|
(468 |
) |
||||
Deferred revenue | 24 |
|
1,862 |
|
||||
Accounts receivables | (490 |
) |
5,560 |
|
||||
CA extended to customers | (109,422 |
) |
(189,927 |
) |
||||
CA collected from customers | 121,990 |
|
206,796 |
|
||||
Other payables | (6,318 |
) |
1,407 |
|
||||
Other long-term liabilities | (3,695 |
) |
(3,582 |
) |
||||
Operating lease right-of-use assets | 5,134 |
|
4,676 |
|
||||
Other assets | (288 |
) |
(3,768 |
) |
||||
Net cash provided by operating activities | 28,874 |
|
16,696 |
|
||||
Cash Flows from Investing Activities | ||||||||
Purchase of property, equipment and software | (5,093 |
) |
(2,044 |
) |
||||
Capitalization of internal use software | (7,772 |
) |
(6,646 |
) |
||||
Severance pay fund (contributions) distributions, net | 481 |
|
(423 |
) |
||||
Customer funds in transit, net | (22,139 |
) |
9,396 |
|
||||
Net cash provided by (used in) investing activities | (34,523 |
) |
283 |
|
||||
Cash Flows from Financing Activities | ||||||||
Exercise of options | 11,312 |
|
16,346 |
|
||||
Outstanding operating balances, net | 739,388 |
|
287,486 |
|
||||
Proceeds from Reverse Recapitalization, net | — |
|
108,643 |
|
||||
Proceeds from PIPE financing, net | — |
|
280,185 |
|
||||
Proceeds from related party facility, net | 1,103 |
|
- |
|
||||
Repayment of long-term debt | — |
|
(40,025 |
) |
||||
Net cash provided by financing activities | 751,803 |
|
652,635 |
|
||||
Effect of exchange rate changes on cash and cash equivalents | (2,491 |
) |
(871 |
) |
||||
Net change in cash, cash equivalents, restricted cash and customer funds | 743,663 |
|
668,743 |
|
||||
Cash, cash equivalents, restricted cash and customer funds at beginning of the period | 4,838,433 |
|
3,413,289 |
|
||||
Cash, cash equivalents, restricted cash and customer funds at end of the period | $ | 5,582,096 |
|
$ | 4,082,032 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220811005217/en/
Investor:
investor@payoneer.com
Media:
PR@payoneer.com
Source:
FAQ
What were Payoneer's Q2 2022 earnings results for PAYO?
What is the updated revenue guidance for Payoneer in 2022?
How did transaction costs change in Q2 2022 for PAYO?